Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Ulcerative Colitis Excellence Forum

Ulcerative Colitis
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

David Rubin
Video
04/30/2024
Dr Rubin provides an in-depth look at the treatment of ulcerative colitis, from setting patient expectations to positioning therapies and monitoring for disease remission or progression.
Dr Rubin provides an in-depth look at the treatment of ulcerative colitis, from setting patient expectations to positioning therapies and monitoring for disease remission or progression.
Dr Rubin provides an in-depth...
04/30/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
04/25/2024
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive...
04/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcasts
03/20/2024
In this episode of IBD Drive Time, Dr Raymond Cross and guest Dr Corey Siegel review the key issues surrounding the care of patients hospitalized due to acute severe ulcerative colitis.
In this episode of IBD Drive Time, Dr Raymond Cross and guest Dr Corey Siegel review the key issues surrounding the care of patients hospitalized due to acute severe ulcerative colitis.
In this episode of IBD Drive...
03/20/2024
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Video
02/26/2024
Dr Cross reviews the highlights of his presentation on recommendations for initial diagnostics and treatment in the care of the hospitalized patient with ulcerative colitis.
Dr Cross reviews the highlights of his presentation on recommendations for initial diagnostics and treatment in the care of the hospitalized patient with ulcerative colitis.
Dr Cross reviews the highlights...
02/26/2024
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Conference Coverage
11/08/2023
Dr Loftus, from Mayo Clinic in Rochester, Minnesota, reviews results from the phase 3 INSPIRE trial of risankizumab for induction of remission among patients with moderate to severe ulcerative colitis.
Dr Loftus, from Mayo Clinic in Rochester, Minnesota, reviews results from the phase 3 INSPIRE trial of risankizumab for induction of remission among patients with moderate to severe ulcerative colitis.
Dr Loftus, from Mayo Clinic in...
11/08/2023
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti, MD
Conference Coverage
07/21/2023
Jessica Allegretti, MD, from Brigham and Women's Hospital, identified high risk factors for progressive disease, reviewed monotherapy vs combination therapy, and emphasized on the importance of treat-to-target at the AIBD meeting.
Jessica Allegretti, MD, from Brigham and Women's Hospital, identified high risk factors for progressive disease, reviewed monotherapy vs combination therapy, and emphasized on the importance of treat-to-target at the AIBD meeting.
Jessica Allegretti, MD, from...
07/21/2023
Advances in Inflammatory Bowel Disease Network
Millie Long, MD
Conference Coverage
06/21/2023
Dr Millie Long reviewed the updates in the management of ulcerative colitis, and how to position them, at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Millie Long reviewed the updates in the management of ulcerative colitis, and how to position them, at the Advances in Inflammatory Bowel Diseases regional meeting.
Dr Millie Long reviewed the...
06/21/2023
Advances in Inflammatory Bowel Disease Network
Florian Rieder, MD
Conference Coverage
06/16/2023
Florian Rieder, MD, addressed the optimal positioning of antitumor necrosis factors and anti-integrins among patients with Crohn disease and ulcerative colitis.
Florian Rieder, MD, addressed the optimal positioning of antitumor necrosis factors and anti-integrins among patients with Crohn disease and ulcerative colitis.
Florian Rieder, MD, addressed...
06/16/2023
Advances in Inflammatory Bowel Disease Network
Millie Long, MD
Conference Coverage
06/15/2023
Optimizing therapies to reach predefined goals, including biologic as well as symptomatic targets, could help achieve remission among patients with ulcerative colitis, Dr Long said at the AIBD regional meeting.
Optimizing therapies to reach predefined goals, including biologic as well as symptomatic targets, could help achieve remission among patients with ulcerative colitis, Dr Long said at the AIBD regional meeting.
Optimizing therapies to reach...
06/15/2023
Advances in Inflammatory Bowel Disease Network
Jess Allegretti
Video
06/13/2023
Dr Allegretti reviews the results of the phase 3 QUASAR trial of the interleukin-23 inhibitor guselkumab in ulcerative colitis.
Dr Allegretti reviews the results of the phase 3 QUASAR trial of the interleukin-23 inhibitor guselkumab in ulcerative colitis.
Dr Allegretti reviews the...
06/13/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement